Susquehanna International Group, LLP Enlivex Therapeutics Ltd. Put Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 07, 2024
BUY
$2.54 - $4.3 $30,226 - $51,170
11,900 New
11,900 $45,000
Q4 2022

Feb 14, 2023
SELL
$3.74 - $4.81 $217,294 - $279,461
-58,100 Reduced 74.11%
20,300 $79,000
Q3 2022

Nov 14, 2022
BUY
$4.11 - $5.87 $144,261 - $206,037
35,100 Added 81.06%
78,400 $333,000

Others Institutions Holding ENLV

# of Institutions
22
Shares Held
2.1M
Call Options Held
16.1K
Put Options Held
3.4K
View Full List

About Enlivex Therapeutics Ltd.

ENLV Quotes by TradingView
  • Ticker ENLV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,403,200
  • Market Cap $23.4M
  • Description
  • Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...
More about ENLV
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email